Clinical Trials for Von Willebrand Disease, Type 3

Find clinical trials for von willebrand disease, type 3. Discover research opportunities and treatment options in your area.

4 Active Trials Found

Showing 4 trials on this page

Page 1 of 1

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

NCT ID: NCT06998524

This clinical trial is investigating the effectiveness and safety of a medication called emicizumab for patients with Type 3 von Willebrand disease (VWD), a condition that affects blood clotting. T...

Recruiting

Phase: PHASE3 Type: interventional Locations: Madrid, , Spain, Leuven, , Belgium +7 more

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

NCT ID: NCT05500807

This clinical trial is studying a medication called Emicizumab (also known as Hemlibra) for patients with severe Von Willebrand Disease (VWD) and those who have both VWD and Hemophilia A. VWD is a ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, Peoria, Illinois, United States +8 more

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

NCT ID: NCT06883240

This clinical trial is looking at how effective and safe the standard treatment is for people with Type 3 von Willebrand Disease (VWD), a bleeding disorder, when they receive regular preventive car...

Recruiting

Type: observational Locations: Madrid, , Spain, Toronto, Ontario, Canada +16 more

Early Check: Expanded Screening in Newborns

NCT ID: NCT03655223

Enrolling by invitation

Type: observational Locations: Research Triangle Park, North Carolina, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions